BPH - Benign Prostatic Enlargement
Seidlitzia rosmarinus for lower urinary tract symptoms associated with benign prostatic hyperplasia: A pilot randomized controlled clinical trial - Abstract
September 23, 2014
Effects of medical therapy or surgery on prostatic and bladder resistive indices in patients with benign prostatic hyperplasia - Abstract
September 17, 2014
Long-term use of 5α-reductase inhibitors and the risk of male breast cancer - Abstract
September 16, 2014
Comparative evaluation of naftopidil and tamsulosin in the treatment of patients with lower urinary tract symptoms with benign prostatic hyperplasia - Abstract
September 9, 2014
Lower urinary tract symptoms in men - Abstract
September 9, 2014
Impact of alpha blockers, 5-alpha reductase inhibitors and combination therapy on sexual function - Abstract
September 3, 2014
Absorption of irrigation fluid occurs frequently during high-power 532nm laser vaporization of the prostate - Abstract
September 1, 2014
Phosphodiesterase type 5 inhibitors for lower urinary tract symptoms induced by benign prostatic hyperplasia: An update - Abstract
August 27, 2014
A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction - Abstract
August 26, 2014